Skip to main content
  • Book
  • © 2021

SARS-CoV-2 Spike Protein Convergent Evolution

Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines

  • Provides a comprehensive overview on relevant SARS-CoV-2 variants
  • Discusses the mechanisms of convergent evolution of the viral spike protein
  • Explores how mutated strains impact the efficacy of Covid-19 vaccines

Part of the book series: SpringerBriefs in Microbiology (BRIEFSMICROBIOL)

Buy it now

Buying options

eBook USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (12 chapters)

  1. Front Matter

    Pages i-xiii
  2. Whole Genome Mutation Rates

    • Daniele Focosi
    Pages 9-10
  3. Phylogenetic Systems

    • Daniele Focosi
    Pages 11-21
  4. SARS-CoV-2 Variants

    • Daniele Focosi
    Pages 55-71
  5. Characterization of SARS-CoV-2 Variants

    • Daniele Focosi
    Pages 73-74
  6. Which Strain Will Finally Become Dominant?

    • Daniele Focosi
    Pages 97-99
  7. Conclusions

    • Daniele Focosi
    Pages 101-102
  8. Back Matter

    Pages 103-136

About this book

This book reviews the current knowledge of the globally circulating SARS-CoV-2 variants, highlights their distinct genetic characteristics and associated conformational changes in the viral spike protein, and profoundly discusses the mechanisms of convergent evolution that led to the rise of these mutated strains at different geographic regions during the Covid-19 pandemic. Furthermore, the book explores how these variants do and may impact the efficacy of established neutralizing antibody-based (nAb) vaccines and therapeutics by analysing latest in vivo and in vitro clinical data. Finally, the author discusses ways on how nAb Covid-19 treatment derived immune escape of SARS-CoV-2 could be minimized in the future.

Authors and Affiliations

  • North-Western Tuscany Blood Bank, Pisa University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

    Daniele Focosi

About the author

Dr. Daniele Focosi was born in Lucca (Italy) in 1980. He graduated in medicine with full grades in 2005 at the University of Pisa and completed specialization in hematology in 2009. Furthermore, he achieved a Ph.D. degree in clinical and fundamental virology in 2014 and a master’s degree in clinical trials in oncology-hematology in 2014.

Dr. Focosi has authored over 150 peer-reviewed manuscripts indexed on PubMed, for a total h-index of 30. He has been a fellow of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste and of the Collegio Ghislieri in Pavia, Italy. He is currently employed full time at the Pisa University Hospital.

He has given numerous oral and poster presentations at international medical congresses and is Member of the editorial board of 17 peer-reviewed journals.

He has received awards from the European Federation of Immunogenetics, the European Society for Organ Transplantation, the Italian Society for Hematology, the Italian Interregional Transplant Association, the Italian Bone Marrow Donor Association, the Italian Society for Experimental Hematology, and the Italian Society against Leukemia/Lymphoma/Myeloma.


Bibliographic Information

  • Book Title: SARS-CoV-2 Spike Protein Convergent Evolution

  • Book Subtitle: Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines

  • Authors: Daniele Focosi

  • Series Title: SpringerBriefs in Microbiology

  • DOI: https://doi.org/10.1007/978-3-030-87324-0

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Author(s), under exclusive license to Springer Nature Switzerland AG 2021

  • Softcover ISBN: 978-3-030-87323-3Published: 12 October 2021

  • eBook ISBN: 978-3-030-87324-0Published: 11 October 2021

  • Series ISSN: 2191-5385

  • Series E-ISSN: 2191-5393

  • Edition Number: 1

  • Number of Pages: XIII, 136

  • Number of Illustrations: 9 b/w illustrations, 2 illustrations in colour

  • Topics: Virology, Immunology, Medical Microbiology, Microbial Genetics and Genomics

Buy it now

Buying options

eBook USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access